Noctrix Health

Country:
USA
Founding year:
2018

Noctrix Health is a neurotechnology company developing non-invasive neuromodulation systems aimed at treating chronic neurological and sleep-related disorders. The company focuses on peripheral nerve stimulation approaches designed to modulate neural circuits involved in sensory and motor regulation.

Its platform delivers controlled electrical stimulation through wearable or externally applied devices, targeting specific peripheral nerves to influence central nervous system activity. The approach is designed to be used outside of surgical settings and emphasizes ease of deployment, patient comfort, and repeatable therapy delivery.

Noctrix Health’s technology is intended for clinical use, with initial indications including sleep-related movement disorders and other neurological conditions. The company positions its systems as therapeutic neuromodulation solutions rather than diagnostic or imaging tools.

Neuromodulation
Therapeutics
Clinical Workflows

Neurofounders Insights

Modality:
Nerve stimulator
Form Factor:
Patch
Interface Depth:
Non-invasive
Indication:
Sleep
Target user:
Patients
Regulatory stage:
FDA cleared (501k)

Series C+

Noctrix Health is one of the clearer clinical winners in wearable neuromodulation for sleep-related disorders, using targeted peripheral nerve stimulation in a non-invasive format. Its FDA-cleared status and narrow indication create a focused, defensible market position.

Related companies

Articles featuring

Noctrix Health

No articles yet!

Press releases

No press releases published yet.